Agios Pharma (AGIO) Tops Q3 EPS by 3c; Reports Cash and Cash Equivalents of $1.4B

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.56), $0.03 better than the analyst estimate of ($1.59).

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Eversource completes $2.4B sale of Aquarion Water Company
• Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET